Nanocatalyzed Hydrogen Isotope Exchange

Marco Lepron (1) , Marion Daniel-Bertrand (1) , Gabriel Mencia (2) , Bruno Chaudret (2) , Sophie Feuillastre (1) , Grégory Pieters (1)

1 MTS - Médicaments et Technologies pour la Santé
2 LPCNO - Laboratoire de physique et chimie des nano-objets

Conspectus. Recently, Hydrogen Isotope Exchange (HIE) reactions have experienced an impressive development due to the growing importance of isotope containing compounds in various fields including materials and life sciences, beside their classical use for mechanistic studies in chemistry and biology. Tritium-labelled compounds are also of crucial interest to study the in vivo fate of a bioactive substance or in radioligand binding assays. Over the past few years, deuterium-labelled drugs have been extensively studied for the improvement of ADME (Absorption, Distribution, Metabolism, Excretion) properties of existing bioactive molecules as a consequence of the primary kinetic isotope effect. Furthermore, in the emergent “omic” fields, the need for new stable isotopically labeled internal standards (SILS) for quantitative GC- or LC-MS analyses is increasing. Because of their numerous applications, the development of powerful synthetic methods to access deuterated and tritiated molecules with either high isotope incorporation and/or selectivities is of paramount importance. HIE reactions allow a late-stage incorporation of hydrogen isotopes in a single synthetic step, thus representing an advantageous alternative to conventional multistep synthesis approaches which are time- and resource-consuming. Moreover, HIE reactions can be considered as the most fundamental C–H functionalization processes and are therefore of great interest for the chemists’ community. Depending on the purpose, HIE reactions must either be highly regioselective or allow a maximal incorporation of hydrogen isotopes, sometimes both. In this context, metal-catalyzed HIE reactions are generally performed using either homogeneous or heterogeneous catalysis which may have considerable drawbacks including an insufficient isotope incorporation and a lack of chemo- and/or regioselectivity, respectively. Over the past 6 years, we have shown that nanocatalysis can be considered as a powerful tool to access complex labeled molecules (e.g., pharmaceuticals, peptides and oligonucleotides) via regio- and chemoselective or even enantiospecific labeling processes occurring at the surface of metallic nanoclusters (Ru or Ir). Numerous heterocyclic (both saturated and unsaturated) and acyclic scaffolds have been labeled with an impressive functional group tolerance, and highly deuterated compounds or high molar activity tritiated drugs have been obtained. An insight into mechanisms has also been provided by theoretical calculations to explain the regioselectivities of the isotope incorporation. Our studies have suggested that undisclosed key intermediates, including 4- and 5-membered dimetallacycles, account for the particular regioselectivities observed during the process, in contrast to the 5- or 6-membered metallacycle key intermediates usually encountered in homogeneous catalysis. These findings together with the important number of available coordination sites explain the compelling reactivity of metal nanoparticles, in between homogeneous and heterogeneous catalysis. They represent innovative tools combining the advantages of both methods for the isotopic labeling and activation of C–H bonds of complex molecules.

Domaines: Chimie

Marco Lepron, Marion Daniel-Bertrand, Gabriel Mencia, Bruno Chaudret, Sophie Feuillastre, et al.. Nanocatalyzed Hydrogen Isotope Exchange. Accounts of Chemical Research, 2021, 54 (6), pp.1465-1480. ⟨10.1021/acs.accounts.0c00721⟩. ⟨hal-03276430⟩